(19)
(11) EP 4 739 655 A2

(12)

(88) Date of publication A3:
13.02.2025

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24739519.7

(22) Date of filing: 03.07.2024
(51) International Patent Classification (IPC): 
C07D 211/40(2006.01)
C07D 401/04(2006.01)
C07D 401/14(2006.01)
A61K 31/435(2006.01)
 C07D 211/56(2006.01)
C07D 401/12(2006.01)
A61P 37/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 211/40; C07D 211/56; C07D 401/04; C07D 401/12; C07D 401/14; A61P 37/00
(86) International application number:
PCT/EP2024/068750
(87) International publication number:
WO 2025/008409 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 03.07.2023 SE 2350829

(71) Applicant: Nestor, Marika
752 63 Uppsala (SE)

(72) Inventors:
  • BENGTSSON, Christoffer
    16860 Bromma (SE)
  • YNGVE, Ulrika
    75752 Uppsala (SE)
  • BEGNINI, Fabio
    11137 Stockholm (SE)
  • JHA, Preeti
    Houston, TX 77025 (US)
  • ROSENSTRÖM, Ulrika
    757 57 Uppsala (SE)
  • NESTOR, Marika
    752 63 Uppsala (SE)

(74) Representative: Potter Clarkson 
Chapel Quarter Mount Street
Nottingham NG1 6HQ
Nottingham NG1 6HQ (GB)

   


(54) SUBSTITUTED 2-PHENYLPIPERIDINE COMPOUNDS FOR USE IN THE DIAGNOSIS, TREATMENT AND/OR PREVENTION OF CANCER